Together, these data suggest NRG-1 as a critical factor for mediating the resistance to apoptosis conferred by Ang II in MASMCs, and NRG-1 may be a potential therapeutic target for vascular remodeling associated with RAAS overactivation in atherosclerosis, hypertension and vascular diseases. This evidence concerns the gene NRG1 and Hypertension.